NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pramana Pharmaceuticals

Pramana Pharmaceuticals

Private
VancouverHealthcare & Life Scienceshttps://www.pramanapharma.com/

Last Round

Grant

Jan 7, 2026

Total Funding Raised

$1M

Company Overview

Pramana Pharmaceuticals is a biotechnology company that develops next-generation oral small-molecule therapies targeting metabolic signaling pathways for neurodegenerative and cardio-metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysmall-molecule therapyGPR119 agonistmetabolic diseaseneurodegenerative diseaseAlzheimer's researchoral drugbiotech startupclinical-stage biotechdrug pipelinemetabolic signalingpharma licensingtherapeutic intervention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pramana Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Pramana Pharmaceuticals comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pramana Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 7, 2026

Pramana Pharmaceuticals Investors

Notable investors and investment history

Pramana Pharmaceuticals investors
InvestorRounds
StartUp HealthGrant

Pramana Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pramana Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pramana Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver
Year Founded2023
Last FundingJan 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.